CME Group's strong performance and market-agnostic revenues support its resilience. Find out why CME stock is a Hold.

CME Group offers strong cash flow, market dominance, and a resilient business model. Click here to see why CME stock is a Buy ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

This was the stock's second consecutive day of losses.

Appalaches Capital, an investment management firm, released its first quarter 2025 investor letter. A copy of the letter can ...

Valued at $101.7 billion by market cap, CME Group Inc. (CME) operates as the world’s leading derivatives marketplace. The ...

Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

The latest price target for CME Group (NASDAQ:CME) was reported by UBS on April 25, 2025. The analyst firm set a price target for $305.00 expecting CME to rise to within 12 months (a possible 5.55 ...

CME Group Inc., together with its subsidiaries ... In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...